Abstract | BACKGROUND: RESULTS: The average course of the treatment was 15 days in the targeted chemotherapy group which was significantly shorter than that in the control group (31 days) (P<0.01). The remission rate of lesions was 91.6% in the targeted chemotherapy group and 60.9% in the control group, respectively. Among these patients, 9 died within two years, including 2 (both at IV stage) in the targeted chemotherapy group and 7 (2 at stage II, 4 at stage III and 1 at stage IV) in the control group. CONCLUSIONS:
|
Authors | Jinsong He, Xianming Wang, Hong Guan, Weicai Chen, Ming Wang, Huisheng Wu, Zun Wang, Ruming Zhou, Shuibo Qiu |
Journal | Radiology and oncology
(Radiol Oncol)
Vol. 45
Issue 2
Pg. 123-8
(Jun 2011)
ISSN: 1581-3207 [Electronic] Poland |
PMID | 22933945
(Publication Type: Journal Article)
|